Stereotaxis (STXS) Gains from Sales and Divestitures (2012 - 2026)
Stereotaxis (STXS) reported Gains from Sales and Divestitures of $115000.0 for Q1 2026, down 4.17% year-over-year from $120000.0 in Q1 2025, and down 52.08% quarter-over-quarter from $240000.0 in Q4 2025.
Stereotaxis (STXS) Gains from Sales and Divestitures (2012 - 2026) Analysis & Trends
Stereotaxis (STXS) has 15 years of Gains from Sales and Divestitures data on file, last reported at $115000.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $115000.0, down 4.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $115000.0 (down 4.17% YoY), and the FY2025 annual result was $240000.0, down 63.22% from the prior year.
- Gains from Sales and Divestitures declined to $115000.0 in Q1 2026 per STXS's latest filing, from $240000.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $652544.0 in Q3 2024 and troughed at $10699.0 in Q1 2022.
- A 5-year average of $226892.2 and a median of $144054.0 in 2023 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2022 and 2023: Gains from Sales and Divestitures plunged 96.07% in 2022, then surged 1246.42% in 2023.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $110726.0 in 2022, then soared by 185.97% to $316646.0 in 2023, then surged by 106.08% to $652544.0 in 2024, then sank by 63.22% to $240000.0 in 2025, then sank by 52.08% to $115000.0 in 2026.
- Business Quant data shows STXS's Gains from Sales and Divestitures at $115000.0 in Q1 2026, $240000.0 in Q4 2025, and $240000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 115,000.00 |
| Mar 31, 2026 | 115,000.00 |
| Dec 31, 2025 | 240,000.00 |
| Dec 31, 2025 | 240,000.00 |
| Sep 30, 2025 | 240,000.00 |
| Sep 30, 2025 | 240,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Mar 31, 2025 | 120,000.00 |
| Dec 31, 2024 | 652,544.00 |
| Dec 31, 2024 | 652,544.00 |
| Sep 30, 2024 | 652,544.00 |
| Sep 30, 2024 | 652,544.00 |
| Jun 30, 2024 | 492,584.00 |
| Jun 30, 2024 | 492,584.00 |
| Mar 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Sep 30, 2023 | 316,646.00 |
| Sep 30, 2023 | 316,646.00 |